A more complete overview of Itovebi side effects, including tips that may help, can be found at Side Effects & Tips.
This page can help you understand why blood sugar levels may rise with Itovebi treatment, how blood sugar levels are monitored, and what you and your healthcare provider (HCP) can do to help manage them.
High blood sugar is not a sign that something has gone wrong with your treatment. It happens because of how Itovebi works in your body.
Normally, a hormone called insulin helps control your blood sugar, letting it move from your bloodstream into your cells (like in your muscles and fat) to be used for energy or stored. Insulin also tells your liver not to make too much sugar.
Itovebi can block these normal insulin signals. This means sugar might not move into your cells as easily, and your liver might produce more sugar, leading to higher blood sugar levels. It's important to work with your HCP to manage high blood sugar levels to help you stay on treatment.
Your HCP may monitor your fasting blood glucose in their office or clinic, or may ask you to self-monitor and report your fasting glucose levels at home.
“Fasting” means not eating or drinking anything except water for at least 8 hours (usually overnight) before your blood glucose measurement.
Monitoring will be required more frequently in the first 4 weeks of treatment. If your HCP suggests you monitor at home, ask them to recommend a glucose monitoring method for you.
Review the discussion guide for glucose monitoring to prepare for a conversation with your HCP.
Download the Blood Glucose Tracking Worksheet to keep track of your fasting blood glucose levels. Share the worksheet with your HCP at your appointments.
Fasting glucose level
| Once | before starting Itovebi |
| Week 1 | every 3 days |
| Weeks 2-4 | once a week |
| Weeks 5-12 | once every 2 weeks |
| After Week 12 | once every 4 weeks and when your doctor feels it's needed |
Hemoglobin A1C
| Once | before starting Itovebi |
| Once | every 3 months and when your doctor feels it's needed |
If you have a history of Type 2 diabetes, your blood sugar level monitoring may be more frequent.
†The time to first onset of hyperglycemia ranged from 2 to 955 days.
Receive one-on-one information sessions about Itovebi at no cost*
*Nurse Educators are representatives of Genentech and do not give medical advice. Please contact your healthcare provider if you experience side effects or need medical advice. A Nurse Educator can help with additional support and tips.
PI3K
A type of protein that transmits signals in cells and is involved in cell growth
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)
A gene that helps make the PI3K protein. Mutations in the PIK3CA gene may cause PI3K to become overactive, which may make cancer cells grow
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.